Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Unraveling the History of Exosomes
Description
In this presentation by Dr. Jeffrey Rappaport, the history and significance of exosomes are discussed, especially in the context of dermatology. Exosomes, which are nano-sized extracellular vesicles involved in cellular communication and cargo transport, have applications in skin rejuvenation and hair restoration. Historical insights trace the understanding of exosomes from their initial identification in blood in 1945 to their current recognition as vital players in cell-to-cell communication and regenerative medicine. Key studies highlight their roles in promoting fibroblast activity, collagen synthesis, and healing processes, particularly notable in hair restoration treatments. The discourse covers the advancement of exosome therapy and its applications, including in PRP (platelet-rich plasma) therapies that leverage exosomes for healing and rejuvenation. Although exosome treatments have shown promise, particularly for conditions like alopecia and wound healing, the regulatory landscape remains complex, with a cautionary note on the lack of FDA approval for such therapies in dermatology. Innovative delivery techniques, such as micro-needling and hydrogels, are emerging to enhance exosome effectiveness. Overall, exosomes are shifting from being viewed as waste to pivotal elements in regenerative treatments, paving the way for novel advancements in aesthetic medicine.
View moreConclusions
- Exosomes facilitate intercellular communication and transport crucial biomolecules like proteins, lipids, and nucleic acids.
- Exosomes derived from adipose stem cells show promise in dermatology, particularly in skin rejuvenation and hair restoration.
- Topical applications of adipose stem cell-derived exosomes can significantly increase hair density and thickness in patients with androgenetic alopecia.
- Exosomes exhibit bioactive properties that promote angiogenesis, collagen formation, and wound healing, while reducing scarring.
- Utilizing autologous serum-derived exosomes can enhance chronic wound healing without adverse reactions.
- Platelet-rich plasma (PRP) contains a high abundance of exosomes, making it valuable for regenerative therapies.
- Standardized methods for exosome characterization and quality control remain a key challenge and are necessary for clinical application.
- Exosome-based therapies are still not approved by the FDA for dermatological use, indicating a need for further regulatory assessment before widespread clinical utilization.
- Wu 2021 Tissue Eng Regen Med https://doi.org/10.1007/s13770-021-00347-y
- Xiong 2021 Pharmacol Res PMID: 33582246
- Novis 2024 JAAD Reviews https://doi.org/10.1016/j.jdrv.2024.06.006
- Gupta 2021 Dermatol Clin https://doi.org/10.1016/j.det.2021.04.001
- Gupta 2024 JCD PMID: 39618056
- Couch 2021 J Extracell Vesicles PMID: 34919343
- Li 2022 J Invest Dermatol PMID: 35690140
- Wang 2023 Lasers Surg Med DOI: 10.1002/Ism.23628
- Pumford 2024 Mayo Clin Proc PMID: 38839179
- Proffer 2022 Aesthet Surg J PMID: 35689936
- Rosmarwati 202 J Applied Pharma Sci DOI: 10.7324/JAPS.2023.125707
- Rezaie 2022 Cell Commun Signal PMID: 36123730
- Shin H. et al. Int J Dermatol 2015;54(6):730-735; Santoianni P. et al. Dermatol Online J 2004;10(2);24; Shi Y. et al. Adv Healthc Mater 2022;11(19):2200908; Yang G. et al. ACS Nano 2019;13(4):4354-4360; Lee JJ. et al. Clin Anat 2022;35(5):682-685; Shu 2023 Biomater Adv PMID: 37804684; Gupta 2024 JCD PMID: 39618056
- Li 2022 Oxid Med Cell Longev PMID: 36388171
- Yu 2023 J Mol Med PMID: 37691076
- Zhou 2021 Stem Cell Res Ther PMID: 33933157
- Gibello 2023 Pharmacol Res PMID: 36878306